Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism γ-secretase modulators(Gamma-secretase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H19N5O3 |
InChIKeyYOJYAOMAAVBZQG-MRXNPFEDSA-N |
CAS Registry2055505-75-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 30 Aug 2016 |